Skip to main content

Month: February 2024

Philips launches new Azurion neuro biplane system at #ECR2024 to speed up and improve minimally invasive diagnosis and treatment of neurovascular patients

Azurion neuro biplane – 1Azurion neuro biplane – 2February 27, 2024 New image-guided therapy system is a complete interventional solution for confident diagnosis, image guidance, and therapy assessment of patients with stroke or other neurovascular diseases Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced major enhancements to its Image Guided Therapy System – Azurion – with the launch of its new Azurion neuro biplane system. Designed to streamline neurovascular procedures and help care teams make the right decisions faster, treat more patients, and achieve better outcomes, the new interventional system features enhanced 2D and 3D imaging and X-ray detector positioning flexibility. As healthcare providers strive to deliver high-quality...

Continue reading

Silver Bull Provides Update on Its Arbitration Claim Against Mexico

VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) — Silver Bull Resources, Inc. (“Silver Bull” or the “Company”) provides an update on progress with its international arbitration claim against the United Mexican States (“Mexico”). Since our previous update on September 26, 2023, a number of important steps have been achieved in the arbitration process. These include:The appointment of a three-person arbitration panel (the “Tribunal”) by the International Centre for Settlement of Investment Disputes (“ICSID”). The Tribunal convened its first session with the parties on February 13, 2024.Engagement of a quantum expert by the Company to assess the Company’s claim. The evaluation is underway and will serve as the foundation for determining the value of Silver Bull’s claim against Mexico.Establishment of a definitive...

Continue reading

Jyske Realkredit A/S publishes Supplement no 1 to Base prospectus dated 29 June 2023

To Nasdaq Copenhagen A/S                                27 February 2024                                        Announcement no 20/2024 Jyske Realkredit A/S publishes Supplement no 1 to Base prospectus dated 29 June 2023 Jyske Realkredit hereby publish Supplement no. 1 to Base prospectus dated 29 June 2023 for covered bonds, mortgage bonds and bonds issued pursuant to Section 15 of the Danish Mortage-Credit Loans and Mortgage-Credit Bonds etc. Act. Jyske Realkredit’s Base Prospectus dated 29 June 2023 and Supplements are available for download in Danish and English on Jyske Realkredit’s website www.jyskerealkredit.dk. In the event of discrepancies between the original Danish text and the English translation, the Danish text shall prevail. Jyske Realkredit’s Supplement no 1 is also enclosed this announcement. For more information, please...

Continue reading

Arcutis Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Q4 net product revenues for ZORYVE® (roflumilast) cream 0.3% were $13.5 million, a 357% increase compared to the fourth quarter of 2022 and a 67% increase compared to the third quarter of 2023; driven by sequential improvement in gross-to-net (GTN) in the mid 60 percent range, as well as sustained demand growth Received U.S. Food and Drug Administration (FDA) approval for ZORYVE® (roflumilast) topical foam, 0.3%, for the treatment of seborrheic dermatitis in adults and children down to age 9 in December 2023 and launched ZORYVE foam for seborrheic dermatitis in United States in late January 2024 July 7, 2024 PDUFA action date for roflumilast cream, 0.15%, for the treatment of atopic dermatitis in adults and children down to age 6 Strong financial position supports investment in plaque psoriasis and seborrheic dermatitis launches and continued...

Continue reading

IDEX Biometrics ASA – Invitation to presentation of fourth quarter and preliminary results for 2023

Oslo, Norway – 27 February 2024 – IDEX Biometrics will publish its interim report for the fourth quarter and preliminary results for 2023 on Thursday 29 February at 08:00 CET. The interim report will also be available on the company’s website: www.idexbiometrics.com. Webcast:There will be a webcast on Thursday 29 February 2024 at 09:00 CET.  The presentation will be held by Vince Graziani, Chief Executive Officer, and Catharina Ekløf, Chief Commercial Officer. The presentation file will be available at www.idexbiometirics.com, and the webcast presentation can be viewed using the following link: https://idexbiometrics.videosync.fi/q4-2023/ For further information contact:Marianne Bøe, Head of Investor Relations E-mail: marianne.boe@idexbiometrics.com Tel: + 47 918 00186 About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX) is a global...

Continue reading

Huhtamaki’s 2023 Annual Report published

HUHTAMÄKI OYJ STOCK EXCHANGE RELEASE 27.2.2024 AT 12:00 EET Huhtamaki’s 2023 Annual Report published The Huhtamaki Annual Report 2023 has been published on the company’s website at www.huhtamaki.com/investors. It is comprised of four sections, with a Company overview, financials, governance (Corporate Governance Statement and Remuneration Report) and sustainability. The report is available in Finnish and English apart from the Sustainability Report, which is available only in English. The financial statements are published in accordance with the European Single Electronic Format (ESEF) reporting requirements. The audit firm KPMG Oy Ab has provided an independent auditor’s reasonable assurance report on Huhtamaki’s ESEF Financial Statements in accordance with ISAE 3000 (Revised). The Annual Report is attached to this release...

Continue reading

Response to media reports about data theft

Over the past days Danish media have reported stories about a theft of source code involving Netcompany Denmark.  We can confirm one single incident involving a simple theft of Netcompany Denmark source code and user manuals.  We can refute that the incident is a ransomware attack.  The data theft has not affected Netcompany or our customer’s operations and services.  We know how the theft has occurred, the extent of the theft, and that the theft resides around source code and user manuals for Netcompany tools.  Since the simple theft was discovered, we have worked in close collaboration with authorities and have implemented additional mitigating actions to ensure a continued high level of security in our production systems landscape.  We have taken necessary precautions that ensure the stolen files cannot be used to gain unauthorized...

Continue reading

Digital Locations CEO Rich Berliner Discussed the Use of Technology for Monitoring and Fighting Wildfires with Research Scientist

Professor Dale Hamilton described his research focused on post-fire effects analysis and the transition from using drones to satellite imagery for broader coverage SANTA BARBARA, CA, Feb. 27, 2024 (GLOBE NEWSWIRE) — Digital Locations, Inc. (OTCMKTS:DLOC), the developer of Satenna™, a breakthrough technology that will deliver high-speed Internet from satellites directly to smartphones all over the world, today announced that in a recent podcast, its CEO, Rich Berliner, spoke with Dale Hamilton, a professor at Northwest Nazarene University (NNU), about the potential of real-time data transmission and the integration of AI to enhance firefighting efforts. During the discussion, Dr. Hamilton expressed the importance of collaboration and innovation in leveraging technology to improve emergency response and potentially save lives....

Continue reading

Micron Collaborates with Samsung on Galaxy S24 Series to Unlock the Era of Mobile AI Experiences

Samsung’s flagship Galaxy S24 Ultra, S24+ and S24 incorporate Micron’s high-performance, power-efficient LPDDR5X and UFS 4.0 BARCELONA, Spain, Feb. 27, 2024 (GLOBE NEWSWIRE) — Mobile World Congress – Micron Technology, Inc. (Nasdaq: MU) announced today that Samsung has incorporated Micron’s low-power double data rate 5X (LPDDR5X) memory and Universal Flash Storage (UFS) 4.0 mobile flash storage into select devices in the Samsung Galaxy S24 series, which introduces powerful artificial intelligence (AI) to mobile users around the world. The Galaxy S24 series is underpinned by Samsung’s suite of generative AI tools, Galaxy AI, which helps amplify experiences from enabling barrier-free communication to maximizing creative freedom. As these data- and energy-intensive features push the limits of smartphones’ hardware capabilities, Micron’s...

Continue reading

WELL Health Founder & CEO Hamed Shahbazi Appointed Chairman of the Board of HEALWELL AI

Hamed Shahbazi, Founder, Chairman and CEO of WELL Health Technologies has been appointed Chairman of HEALWELL AI, a global leader in AI powered preventative care. Mr. Shahbazi’s appointment is strategically important for shareholders of both WELL and HEALWELL given the shared objective between the companies to create the most advanced and easy to use AI inspired tools that can equip care providers with various ‘Co-Pilots’ that can help them improve diagnosis of rare and chronic diseases, improve efficiency of their practice, and improve patient health outcomes. WELL is currently the largest shareholder of HEALWELL with ownership of 20.7% of the company’s issued and outstanding voting securities. WELL also has an option to acquire approximately 30 million multi-voting shares that would give WELL a controlling position in HEALWELL, as defined...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.